Citigroup Inc Ascendis Pharma A/S Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Citigroup Inc holds 21,268 shares of ASND stock, worth $2.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,268

Previous 25,281 15.87%

Holding current value

$2.9 Million

Previous $3.45 Million 7.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$113.0 - $153.43 $453,469 - $615,714	-4,013 Reduced 15.87%	21,268 $3.18 Million
Q2 2024 Aug 12, 2024	BUY	$121.07 - $153.67 $642,276 - $815,219	5,305 Added 26.56%	25,281 $3.45 Million
Q1 2024 May 10, 2024	BUY	$123.45 - $159.4 $117,524 - $151,748	952 Added 5.0%	19,976 $3.02 Million
Q4 2023 Feb 09, 2024	SELL	$86.1 - $127.36 $1.17 Million - $1.73 Million	-13,553 Reduced 41.6%	19,024 $2.4 Million
Q3 2023 Nov 09, 2023	BUY	$86.5 - $103.97 $714,230 - $858,480	8,257 Added 33.95%	32,577 $3.05 Million
Q2 2023 Aug 10, 2023	SELL	$69.96 - $97.84 $655,385 - $916,565	-9,368 Reduced 27.81%	24,320 $2.17 Million
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $1.56 Million - $1.89 Million	14,913 Added 79.43%	33,688 $3.61 Million
Q4 2022 Feb 09, 2023	BUY	$99.42 - $131.97 $1.74 Million - $2.31 Million	17,496 Added 1367.94%	18,775 $2.29 Million
Q3 2022 Nov 10, 2022	SELL	$84.03 - $110.23 $26,721 - $35,053	-318 Reduced 19.91%	1,279 $132,000
Q2 2022 Aug 10, 2022	SELL	$78.08 - $117.61 $23,892 - $35,988	-306 Reduced 16.08%	1,597 $149,000
Q1 2022 May 12, 2022	SELL	$102.18 - $135.75 $54,564 - $72,490	-534 Reduced 21.91%	1,903 $223,000
Q4 2021 Feb 10, 2022	SELL	$127.1 - $169.66 $141,208 - $188,492	-1,111 Reduced 31.31%	2,437 $328,000
Q3 2021 Nov 10, 2021	BUY	$112.67 - $176.92 $399,753 - $627,712	3,548 New	3,548 $566,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account